Watch for Gallbladder Problems in Patients Using GLP-1 Agonists
October 2016
You'll hear more about a possible link between gallbladder disease and GLP-1 agonists...such as Victoza (liraglutide) or Byetta (exenatide).
The latest evidence suggests that about one in 357 patients on liraglutide or exenatide over about 3 years will be hospitalized for bile duct or gallbladder disease...compared to patients on other diabetes meds.
Patients with diabetes already have a higher risk of bile duct and gallbladder disease. But GLP-1 agonists may increase this risk...possibly by causing rapid weight loss in some patients.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive